Option Care Health (NASDAQ:OPCH) Shares Gap Down – Should You Sell?

Option Care Health, Inc. (NASDAQ:OPCH) shares gapped down before the market opened on Wednesday . The stock had previously closed at $32.63, but opened at $31.44. Option Care Health shares last traded at $33.18, with a volume of 907,388 shares changing hands.

Analyst Ratings Changes

A number of research firms have weighed in on OPCH. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, Barrington Research increased their target price on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and an average price target of $32.25.

Option Care Health Trading Up 1.6 %

The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.64 billion, a PE ratio of 27.89, a PEG ratio of 2.30 and a beta of 1.35. The stock has a fifty day moving average of $28.07 and a two-hundred day moving average of $28.00.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, February 26th. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.02. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

Large investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio boosted its stake in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after acquiring an additional 332 shares during the last quarter. Cornerstone Investment Partners LLC boosted its stake in Option Care Health by 3.6% during the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after buying an additional 333 shares during the period. UMB Bank n.a. grew its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the last quarter. Assetmark Inc. grew its holdings in shares of Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after purchasing an additional 487 shares during the last quarter. Finally, Lindenwold Advisors INC lifted its stake in Option Care Health by 5.4% in the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after acquiring an additional 489 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.